Comparative study of interactions between chloroquine and chlorpheniramine or promethazine in healthy volunteers: A potential combination-therapy phenomenon for resuscitating chloroquine for malaria treatment in Africa

Annals of Tropical Medicine and Parasitology

Volumn 102, Issue 1, 2008, Pages 3-9

  Gbotosho, G O ^a,b   Happi, C T ^a,b   Sijuade, A ^a,b   Ogundahunsi, O A T ^c   Sowunmi, A ^a,b   Oduola, A M J ^a,c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CHLORPHENIRAMINE; PROMETHAZINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; ERYTHROCYTE; HUMAN; HUMAN EXPERIMENT; MALARIA; MALE; MONOTHERAPY; NORMAL HUMAN;

ADULT; ANIMALS; ANTIMALARIALS; AREA UNDER CURVE; CHLOROQUINE; CHLORPHENIRAMINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HISTAMINE H1 ANTAGONISTS; HUMANS; MALARIA, FALCIPARUM; MALE; NIGERIA; PLASMODIUM FALCIPARUM; PROMETHAZINE;

EID: 38749091374     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485908X252179     Document Type: Article

References (29)

1. Bitonti, A. J., Sjoerdsma, A., McCann, P. P., Kyle, D. E., Oduola, A. M., Rossan, R. N., Milhous, W. K. & Davidson Jr, D. E. (1988). Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science, 242, 1301-1303.
2. Bloland, P. B. (2003). A contrarian view of malaria therapy policy in Africa. American Journal of Tropical Medicine and Hygiene, 68, 125-126.
3. Bioland, P. B., Ettling, M. & Meek, S. (2000). Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization, 78, 1378-1388.
4. Boulter, M. K., Bray, P. G., Howells, R. E. & Ward, S. A. (1993). The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparum is reduced by its binding to plasma protein. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 303.
5. Bray, P. G., Howells, R. E., Ritchie, G. Y. & Ward, S. A. (1992). Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation. Biochemical Pharmacobgy, 44, 1317-1324.
6. Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Dicko, A., Su, X. Z., Nomura, T., Fidock, D. A., Wellems, T. E., Plowe, C. V. & Coulibaly, D. (2001). A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine, 344, 257-263.
7. Falade, C. O., Salako, L. A., Sowunmi, A., Oduola, A. M. & Larcier, P. (1997). Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 58-62.
8. Fidock, D. A., Nomura, T., Talley, A. K., Cooper, R. A., Dzekunov, S. M., Ferdig, M. T., Ursos, L. M., Sidhu, A. B., Naude, B., Deitsch, K. W., Su, X. Z., Wootton, J. C., Roepe, P. D. & Wellems, T. E. (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell, 6, 861-871.
9. Happi, C. T., Gbotosho, G. O., Sowunmi, A., Falade, C. O., Akinboye, D. O., Gerena, L., Kyle, D. E., Milhous, W., Wirth, D. F. & Oduola, A. M. (2004). Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. American Journal of Tropical Medicine and Hygiene, 70, 20-26.
10. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M., Martin, S. K., Milhous, W. K. & Schlesinger, P. H. (1987). Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science, 238, 1283-1285.
11. Kyle, D. E., Oduola, A. M., Martin, S. K. & Milhous, W. K. (1990). Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 474-478.
12. Kyle, D. E., Milhous, W. K. & Rossan, R. N. (1993). Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. American Journal of Tropical Medicine and Hygiene, 48, 126-133.
13. Martin, S. K., Oduola, A. M. & Milhous, W. K. (1987). Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science, 235, 899-901.
14. Mberu, E. K., Mosobo, M. K., Nzila, A. M., Kokwaro, G. O., Sibley, C. H. & Watkins, W. M. (2000). The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. American Journal of Tropical Medicine and Hygiene, 62, 396-401.
15. Na-Bangchang, K., Limpaibul, L., Thanavibul, A., Tan-Ariya, P. & Karbwang, J. (1994). The pharmacokinetics of chloroquine in healthy subjects and patients with Plasmodium vivax malaria. British Journal of Clinical Pharmacology, 38, 278-281.
16. Nzila, A., Mberu, E., Bray, P., Kokwaro, G., Winstanley, P., Marsh, K. & Ward, S. (2003). Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrobial Agents and Chemotherapy, 47, 2108-2112.
17. Oduola, A. M., Sowunmi, A., Milhous, W. K., Brewer, T. G., Kyle, D. E., Gerena, L., Rossan, R. N., Salako, L. A. & Schuster, B. G. (1998). In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. American Journal of Tropical Medicine and Hygiene, 58, 625-629.
18. Peters, W., Ekong, R., Robinson, B. L., Warhurst, D. C. & Pan, X. Q. (1989). Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet, ii, 334-335.
19. Pradines, B., Alibert-Franco, S., Houdoin, C., Mosnier, J., Santelli-Rouvier, C., Papa, V., Rogier, C., Fusai, T., Barbe, J. & Parzy, D. (2002). In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives. American Journal of Tropical Medicine and Hygiene, 66, 661-666.
20. Price, R. N., Nosten, F., Luxemburger, C., van Vugt, M., Phaipun, L., Chongsuphajaisiddhi, T. & White, N. J. (1997). Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 574-577.
21. Sibley, C. H., Hyde, J. E., Sims, P. F., Plowe, C. V., Kublin, J. G., Mberu, E. K., Cowman, A. F., Winstanley, P. A., Watkins, W. M. & Nzila, A. M. (2001). Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology, 17, 582-588.
22. Sowunmi, A., Oduola, A. M., Ogundahunsi, O. A., Falade, C. O., Gbotosho, G. O. & Salako, L. A. (1997). Enhanced efficacy of chloroquine- chlorpheniramine combination in acute uncomplicated falciparum malaria in children. Transactions of the Royal Society Tropical Medicine and Hygiene, 91, 63-67.
23. Sowunmi, A., Adedeji, A. A., Fateye, B. A. & Fehintola, F. A. (2004). Comparative effects of pyrimethamine-sulfadoxine, with and without probenecid, on Plasmodium falciparum gametocytes in children with acute, uncomplicated malaria. Annals of Tropical Medicine and Parasitology, 98, 873-878.
24. Walker, O. & Ademowo, O. G. (1996). A rapid, cost-effective liquid chromatographic method for the determination of chloroquine and desethylchloroquine in biological fluids. Therapeutic Drug Monitoring, 18, 92-96.
25. Warsame, M., Wernsdorfer, W. H. & Bjorkman, A. (1992). Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 235-236.
26. White, N. J. (1996). The treatment of malaria. New England Journal of Medicine, 335, 800-806.
27. White, N. J. & Olliaro, P. (1998). Artemisinin and derivatives in the treatment of uncomplicated malaria. Médecine Tropicale, 58, 54-56.
28. World Health Organization (2001). Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation, 4-5 April 2001. Document WHO/CDS/RBM/2001.35. Geneva: WHO.
29. Yayon, A., Cabantchik, Z. I. & Ginsburg, H. (1985). Susceptibility of human malaria parasites to chloroquine is pH dependent. Proceedings of the National Academy of Sciences of the United States of America, 82, 2784-2788.